Aquestive Therapeutics Inc reports results for the quarter ended in March - Earnings Summary

Aquestive Therapeutics

03/05/2023 24:16

* Aquestive Therapeutics Inc  AQST.OQ  reported a quarterly
adjusted loss of 12 cents​​ per share for the quarter ended in
March. The mean expectation of five analysts for the quarter was
for a loss of 19 cents per share.
    * Revenue fell 9.3% to $11.13 million from a year ago;
analysts
expected $9.94 million. 
    * Aquestive Therapeutics Inc's reported EPS for the quarter
was 11
cents​.
    * The mean earnings estimate of analysts had risen by
about 22.4%
in the last three months.​ 
    * In the last 30 days, there have been no negative revisions
of
earnings estimates 
    * Aquestive Therapeutics Inc shares had risen by 21.9% this
quarter and gained 54.1% so far this year.
    * The company reported quarterly net income of $8.07
million.
    * Wall Street's median 12-month price target for Aquestive
Therapeutics Inc is $6.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
2 at 11:15 p.m. UTC. ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.19          -0.12          Beat
 Dec. 31 2022      -0.23          -0.23          Met
 Sep. 30 2022      -0.31          -0.23          Beat
 Jun. 30 2022      -0.36          -0.36          Met